Early research (Phase 1)Ended earlyNCT00418132
What this trial is testing
Thalidomide for Decreasing Collagen Biosynthesis in People With Progressive Systemic Sclerosis
Who this might be right for
Scleroderma, Systemic
NYU Langone Health 30
Showing 20 of 0 results